Compound information
- Natural Products
- ZC860743
- Molecular Formula
- C21H29N3O6
- Molecular Weight
- 419.205635648 g/mol
- Structure
-
- IUPAC Name
- benzyl (2R)-2-[[(1R)-1-[(2-methoxy-2-oxo-ethyl)carbamoyl]-2-methyl-propyl]carbamoyl]pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C21H29N3O6/c1-14(2)18(20(27)22-12-17(25)29-3)23-19(26)16-10-7-11-24(16)21(28)30-13-15-8-5-4-6-9-15/h4-6,8-9,14,16,18H,7,10-13H2,1-3H3,(H,22,27)(H,23,26)/t16-,18-/m1/s1
- InChI Key
- TVCNPXGWXYJWMS-SJLPKXTDSA-N
- SMILES
- COC(=O)CNC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)OCc1ccccc1)C(C)C
- Source
- ZINC000005706855
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 114.04 Å2 | LogP | 1.945 |
LogS | -2.951 | LogD | 2.169 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.272 | Pgp substrate | 0.051 |
HIA | 0.962 | F20 % | 0.513 |
F30 % | 0.052 | Caco-2 | -4.944 |
MDCK | -4.814 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.185 | PPB | 37.948 |
VD | 0.62 | Fu | 0.645 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.403 |
CYP2A6 substrate | 0.273 | CYP2B6 substrate | 0.403 |
CYP2C19 inhibitor | 0.62 | CYP2C19 substrate | 0.396 |
CYP2C8 substrate | 0.507 | CYP2C9 inhibitor | 0.059 |
CYP2C9 substrate | 0.856 | CYP2D6 inhibitor | 0.005 |
CYP2D6 substrate | 0.323 | CYP2E1 substrate | 0.329 |
CYP3A4 inhibitor | 0.59 | CYP3A4 substrate | 0.73 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.891 | CL | 4.563 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.002 | Hepatotoxicity | 0.333 |
Mutagenicity | 0.049 | Rat Oral Acute Toxicity | 0.133 |
FDAMDD | 0.169 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.001 |
Eye Irritation | 0.003 | Respiratory Toxicity | 0.008 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.615 | IGC50 | 2.241 |
LC50FM | 2.634 | LC50DM | 4.53 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.327 | NR-AR-LBD | 0.339 |
NR-AhR | 0.003 | NR-Aromatase | 0.022 |
NR-ER | 0.283 | NR-ER-LBD | 0.367 |
NR-PPAR-gamma | 0.159 | SR-ARE | 0.076 |
SR-ATAD5 | 0.301 | SR-HSE | 0.083 |
SR-MMP | 0.01 | SR-p53 | 0.039 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.